Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis
OWL Genomics, biotechnological company, has presented at the CIC bioGUNE hold at the Bizkaia Technological Park (Derio), the first DNA chip concerning diagnosis and prognosis of non-alcoholic steatohepatitis (NASH), allowing the discrimination between normal, steatosis and NASH predisposed subjects. Non alcoholic steatohepatitis is a progressive disease of the liver of unknown etiology, ch...MIT researcher presents new view of how the cortex forms
A leading neuroscientist at MIT and one from the University of California at San Francisco (UCSF) report in the Nov. 4 special issue of Science dedicated to the brain that the controversy is over: The "protomap" and "protocortex" theories of brain development are dead. The cerebral cortex is a sheet of around 10 billion neurons divided into distinctly separate areas that process particular...Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants
Just over a decade ago, biologists isolated a unique protein from jellyfish that could be inserted into other organisms—from to pigs—and cause them to radiate a brilliant green color. This green fluorescent protein (GFP) has allowed biologists to make many new discoveries regarding how living cells function. But one kingdom of life—plants—has presented special challenges to GFP det...The quest for an effective HIV vaccine presents new possibilities, challenges
A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce...NimbleGen presents new tech for comparing microbe DNA
A company statement said the method would be faster and cheaper than other technologies for comparing microbes' genomes but did not include specific price...Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
MADISON - The Institute of Medicine estimates that information errors or a lack of data lead to as many as 100,000 deaths each year. With this startling figure in mind, the Wisconsin Technolo...Thieme Presents Unique Technology Angle at Gov.s Conference
Madison, Wis. Civic and industrial representatives were treated to a unique viewpoint Thursday at the . Tying s...Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
A new study says that symptoms associated with ovarian cancer start much earlier before the diagnosis// is made and being alert to these symptoms could make a huge difference in the rapid treatment of the cancer. Ovarian cancer is more curable if detected early enough. The study team led by Dr. Lloyd H. Smith from the University of California Davis Health System in Sacramento says that t...Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
When Keith Karzin donated half his liver to his mother-in-law in November 2003,// he wanted nothing in return except to save the life of his wife’s mother and his children’s grandmother. But the 45-year-old Valencia resident has been chosen to represent Cedars-Sinai Medical Center on the Donate Life Rose Parade? Float this coming New Year’s Day. “It’s going to be an honor, and...Children's Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
GAY AND LESBIAN TEENS FACE MORE BULLYING In the broadest study of bullying and sexual orientation to date, lesbian/gay adolescents were three to four times more likely to report having been bullied //than heterosexuals while bisexuals and those identifying as 'mostly heterosexual' were twice as likely, after adjustment for age and other factors. 'It’s clear that sexual minority youth are...IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
IDM Pharma, Inc. today presented preliminary results from a Phase II UVIDEM (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). The results showed that UVIDEM was well tolerated with evidence of efficacy and induction of immune response in patients with progressive metastatic melanoma. The data were presented by Merrick I. Ross, M.D., Professor of Surgery, Chief, Melanoma Section...Monogram Presents Results of First ETag Breast Cancer Studies
Monogram Biosciences, Inc. announced that two presentations detailing initial studies on the clinical utility of its proprietary eTag technology in metastatic breast cancer will be presented at the 43rd American Society of Clinical Oncology (ASCO) meeting (June 1-5) in Chicago, Illinois. A third presentation will describe the molecular characterization of cell lines that have acquired re...SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
- Canadian Biotechnology Company updates progress and upcomingmilestones on its insulin program - CALGARY, June 26, 2007 /PRNewswire-FirstCall/ - SemBioSysGenetics Inc. , a biotechnology company developing a portfolio oftherapeutic proteins for metabolic and cardiovascular disease,today announced positive preclinical data supporting thedevelopment of plant-derived recombinant human insuli...